Pharmaceutical Published Insights

Published Date : 02 Apr, 2026

Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a group of autoimmune diseases characterized by inflammation and damage to small blood vessels. Self-reactive antibodies known as ANCAs, which bind to and excessively activate neutrophils, ... View more

Published Date : 02 Apr, 2026

A rare condition known as monkeypox is brought on by infection with the monkeypox virus. The smallpox virus and the monkeypox virus both belong to the same virus family. Monkey pox, however, is not as contagious as smallpox. Additionally, the illness has lesser sympto... View more

Published Date : 02 Apr, 2026

Topical steroids are available in a variety of strengths and are classified into seven classes based on their potency. Class I (class one) contains the strongest steroids, while Class VII contains the weakest (class seven). Topical... View more

Published Date : 02 Apr, 2026

Macular Degeneration is an eye disease affecting the macula (the centre of the light-sensitive retina at the back of the eye), causing loss of central vision. It's generally caused by abnormal blood vessels that leak fluid or blood into the macula. There are 2 types o... View more

Published Date : 02 Apr, 2026

Flumazenil is a benzodiazepine inhibitor Flumazenil are used as reversal drug for postsurgical sedation from benzodiazepine anesthetics. Flumazenil injection is recommended for a complete or partial reversal of the sedative effects of benzodiazepines in conscious seda... View more

Published Date : 02 Apr, 2026

Sjogren’s syndrome is systematic autoimmune disorder which effect the entire body, along with complication such as, chronic pain, major organ involvement, profound fatigue, neuropathies and Sjogren’s syndrome zmphomas. ... View more

Published Date : 02 Apr, 2026

The global liver health supplements market is estimated to be valued at USD 1.34 Bn in 2025 and is expected to reach USD 3.11 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.8% from ... View more

Published Date : 02 Apr, 2026

The global AmBisome market is estimated to be valued at USD 1.44 Bn in 2025 and is expected to reach USD 2.15 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032. The... View more

Published Date : 02 Apr, 2026

The Global Enterogermina Market is estimated to be valued at USD 163.4 Mn in 2025 and is expected to reach USD 255.6 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 20... View more

Published Date : 02 Apr, 2026

The global colorectal cancer market is estimated to be valued at USD 13.74 Bn in 2025 and is expected to reach USD 19.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.8% from 2025 t... View more

Published Date : 02 Apr, 2026

The global rotavirus vaccine market is estimated to be valued at USD 2.51 Bn in 2025 and is expected to reach USD 4.47 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2025 to ... View more

Published Date : 02 Apr, 2026

The Global Albumin Market is estimated to be valued at USD 7.24 Bn in 2025 and is expected to reach USD 12.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032. The... View more

Published Date : 02 Apr, 2026

The global ulcerative colitis drug market is estimated to be valued at USD 9.52 Bn in 2025 and is expected to reach USD 14.79 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2... View more

Published Date : 02 Apr, 2026

The global tofacitinib market is estimated to be valued at USD 3.52 Bn in 2025 and is expected to reach USD 7.68 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032.... View more

Published Date : 02 Apr, 2026

The global desonide market is estimated to be valued at USD 162.5 Mn in 2025 and is expected to reach USD 254.2 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% fro... View more

Published Date : 02 Apr, 2026

The global personal lubricants market is estimated to be valued at USD 1.75 Bn in 2025 and is expected to reach USD 3.30 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.5% from 2025 t... View more

Published Date : 02 Apr, 2026

The global Tay-Sachs disease market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2025 to ... View more

Published Date : 02 Apr, 2026

The global fluoroquinolones market is estimated to be valued at USD 5.10 Bn in 2025 and is expected to reach USD 7.32 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2025 to 2... View more